| Page 58 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Patient and physician perceptions about blood transfusions in the myelodysplastic syndromes

Author(s): 
David King, Rodney Schmidt, Matthew Lesser, Alice Houk, Ellen Salkeld, Christopher R Cogle
Primary Author: 
King, D
Journal Title: 
Leukemia Research
Original Publication Date: 
Jul 2020

Background: Little is known about the shared decision-making between patients with transfusion-dependent (TD)

Bone Marrow Disease(s): 

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysis

Author(s): 
Armin Rashidi, Mohamad A Meybodi, Wenhao Cao, Haitao Chu, Erica D Warlick, Steven Devine, Marcelo C Pasquini, Daniel J Weisdorf, Mehdi Hamadani
Primary Author: 
Armin Rashidi
Journal Title: 
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
Original Publication Date: 
Jun 2020

In a systematic review and meta-analysis, we compared allogeneic transplant outcomes after myeloablative conditioning (MAC) versus reduced-intensity conditioning (RIC) in patients with

Bone Marrow Disease(s):